৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Products
Payment
Delivery
Typhocon – Typhoid Vi Conjugate Vaccine
Indication: Active immunization against infection caused by Salmonella typhi in infants, children, adolescents, and adults aged 6 months to <45 years.
Pharmacology: Clear, colorless solution free from visible particles. Contains 25 µg of Typhoid Vi polysaccharide conjugated to CRM197 carrier protein. Sodium chloride and phosphate buffer act as diluents; 2-phenoxyethanol is added as preservative. Meets ILP & WHO requirements.
Dosage & Administration:
Single 0.5 mL IM injection.
For children ≥2 years, adolescents, and adults: inject into deltoid muscle.
For infants 6 months to <2 years: inject into anterolateral thigh muscle.
Do not inject into gluteal area or near nerve trunks.
Interaction: No clinical data on co-administration. Do not mix with other vaccines or medicinal products.
Contraindications: Hypersensitivity to components, pregnancy & lactation, fever or severe infection.
Side Effects:
Local: Injection site pain (4.5%), erythema (0.64%), swelling (0.32%).
Systemic: Pyrexia (2.35%), vomiting (0.96%), headache (0.64%), fatigue (0.64%), arthralgia (0.32%), rash (0.32%).
Usually mild, resolving within 2–3 days. No serious adverse events reported.
Pregnancy & Lactation: Safety not established; unknown if secreted in breast milk.
Precautions & Warnings:
Do not administer IV, intradermally, or subcutaneously.
Protects only against Salmonella typhi, not paratyphi or other non-typhoidal strains.
Epinephrine injection (1:1000) must be available for anaphylaxis.
Keep under medical supervision for ≥30 minutes post-vaccination.
Therapeutic Class: Vaccines, Anti-sera & Immunoglobulin
Storage: Store at +2°C to +8°C. Do not freeze. Discard if frozen. Shake well before use. Keep out of reach of children.
Prophylaxis of Typhoid fever
Should be taken on an empty stomach. Take 1 hr before meals.
Oral\r\nActive immunisation against typhoid fever caused by Salmonella typhi\r\nAdult: Primary immunisation: Take 1 capsule on alternate days (day 1, 3 and 5) for a total of 3 doses; all doses should be completed at least 1 wk before potential exposure. Booster immunisation: Repeat full course of primary immunisation every 5 yr if exposure continues. \r\n
Oral\r\nActive immunisation against typhoid fever caused by Salmonella typhi\r\nChild: >6 yr: Primary immunisation: Take 1 capsule on alternate days (day 1, 3 and 5) for a total of 3 doses; all doses should be completed at least 1 wk before potential exposure. Booster immunisation: Repeat full course of primary immunisation every 5 yr if exposure continues.
Congenital and acquired immune deficiency, including treatment with immunosuppressive and antimitotic drugs, acute febrile illness and acute intestinal infection. Safety of the vaccination during pregnancy has not yet been established.
Live attenuated oral vaccine; conveys active immunity via stimulation of production of endogenously produced antibodies.
Not for treatment of typhoid fever. Vaccination may not provide full proetction thus, travellers should be advised to take all necessary precautions to avoid contact or ingestion of potentially contaminated food or water sources
Headache, fever, rash, abdominal pain, nausea, diarrhoea, vomiting, anaphylactic reaction, demyelinating disease, myalgia, pain, urticaria, sepsis and weakness.
Concurrent use with antibiotics or immunoglobulins may reduce the efficacy of typhoid vaccine. Mefloquine may increase the efficacy of typhoid vaccine. May reduce the diagnostic effect of tuberculin tests.\r\n\r\nPotentially Fatal: Concurrent use with immunosuppressants may increase the adverse effects of live vaccines.






N/A

